I would estimate that Dr Seymour is having a joyous Holiday Season after the prospect of an ORPHAN DESIGNATION for FLUCIDE as it could work on IMMUNO=COMPROMISED patients came up.
He has a lot friends in the immumo-compromised sectors that have been asking him for such for some time.
Now in an ORAL FORM.
It has taken a log time to get that far. Probably longer for Dr. Seymour and Dr. Diwan than for the investors of NNVC.